ELIDEL / gastroenteritis

United States · event evidence

gastroenteritis

Listed

Increased over vehicle in the 6-week infant study.

Authority: DailyMed, U.S. National Library of Medicine
Document: ELIDEL (PIMECROLIMUS) CREAM [PHYSICIANS TOTAL CARE, INC.]
Jurisdiction: United States
Version / revision: 1
Document date: Not recorded
Source: Official source document

Source evidence

In the 6-week vehicle-controlled study these adverse events included pyrexia (32% vs. 13% vehicle), URI (24% vs. 14%), nasopharyngitis (15% vs. 8%), gastroenteritis (7% vs. 3%), otitis media (4% vs. 0%), and diarrhea (8% vs. 0%).

Section: Not stated
Context: Increased over vehicle in the 6-week infant study.
Frequency: Not stated
Population / denominator: Not stated

Return to label evidence explorer